Baladna, Bel Group enter manufacturing agreement to expand dairy product line in Qatar
Date
2/21/2023 3:09:15 AM
(MENAFN) Qatar's leading food and dairy producer, Baladna, has entered a manufacturing agreement with global cheese and snack giant, The Bel Group, in a landmark collaboration. As per the deal, more of Bel Group's products will be manufactured in Qatar in the near future. The agreement between the two companies began on February 16, 2023.
Malcolm Jordan, CEO of Baladna, expressed his delight on this collaboration with Bel Group, who are known for their cheese products. He said, "This partnership will enable us to extend the range of dairy products available in Qatar and provide customers with high-quality products. As a prominent dairy brand in Qatar, Baladna aims to promote food sustainability efforts in the country. We look forward to utilizing Bel Group's expertise as we seek to expand our line of dairy products and make international brands more accessible in the Qatari market. This partnership will have a positive impact on the dairy industry in Qatar and improve consumer options."
Garo Matossian, CEO of Bel for Near & Middle East, said, "The Bel Group is committed to making our products available to new customers and establishing sustainable partnerships with local producers across the globe. This strategic partnership with Baladna in Qatar is an exciting step forward in our presence in the Middle Eastern Gulf, aligning with our mission to deliver healthier and responsible food for all."
Baladna, established in 2019, was listed on Qatar Stock Exchange in the same year, with an authorized capital of QR1.901 billion and 1,425,750,000 shares.
MENAFN21022023000045014228ID1105607133
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.